Профилактика и интенсивная терапия пневмоний у больных с ишемическим инсультом

Е. А. Попова, С. В. Орлов, М. А. Позднякова et al. · Сибирский медицинский журнал (Иркутск) · 2006

With the purpose of reduction of number of pneumonias and decrease of the death rate in patients with ischemic insult in a acute phase 50 patients of the basic group in complex treatment received in addition Mildronate and Reaferon-ЕС-lipint. Studying condition cellular, humoral immunity, some parameters of the neurologic status, breath, changes КОС and gas structure of blood, have shown, that joint influence on various parts cellular, humoral immunity Mildronate and Reaferon-ЕС-lipint allows to activate effectively the immune cells (that led to decrease in frequency of occurrence of pneumonias at patients of the basic group from 62% up to 26%) and reduction of the general death rate on 26%. Thus, from first days it is necessary to correct the immunity by Mildronate and Reaferon-ЕС-lipint in patients with an ischemic insult.

Cited by 0 works.

Authors